Form 8-K - Current report:
SEC Accession No. 0001104659-20-059085
Filing Date
2020-05-11
Accepted
2020-05-11 06:58:14
Documents
2
Period of Report
2020-05-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2018938d1_8k.htm 8-K 18848
2 EXHIBIT 99.1 tm2018938d1_ex99-1.htm EX-99.1 23508
  Complete submission text file 0001104659-20-059085.txt   43688
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 20862542
SIC: 2836 Biological Products, (No Diagnostic Substances)